

Thursday
February 13, 2025
1:00 AM ET
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
Monday
February 3, 2025
1:30 AM ET
Press Release: Sanofi announces buy back of shares from L’Oréal
Thursday
January 30, 2025
1:30 AM ET
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
Friday
December 6, 2024
1:30 AM ET
Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Wednesday
October 30, 2024
7:00 AM ET
Banco Santander-Chile Announces Third Quarter 2024 Earnings
Friday
October 25, 2024
1:30 AM ET
Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
Monday
October 21, 2024
1:30 AM ET
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare